Universal Ibogaine Inc. announced a non-brokered private placement of up to 23,333,333 common shares at a price of CAD 0.015 per share, for proceeds of up to $349,999.995 on April 22, 2024. The completion of the offering is subject to approval by the TSX Venture Exchange. All shares issued under the offering will be subject to a four-month hold period as required by the rules of the TSXV and Canadian Securities Laws, as well as any required hold periods under US Securities Laws for US resident purchasers.